
MHY1485
CAS No. 326914-06-1
MHY1485 ( MHY-1485 | MHY1485 | MHY 1485 )
产品货号. M14060 CAS No. 326914-06-1
MHY1485 是一种 mTOR 激活剂;通过抑制自噬体和溶酶体之间的融合来抑制自噬过程,从而导致 LC3II 蛋白的积累和自噬体的增大。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥348 | 有现货 |
![]() ![]() |
10MG | ¥494 | 有现货 |
![]() ![]() |
25MG | ¥915 | 有现货 |
![]() ![]() |
50MG | ¥1588 | 有现货 |
![]() ![]() |
100MG | ¥2940 | 有现货 |
![]() ![]() |
200MG | ¥4334 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称MHY1485
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述MHY1485 是一种 mTOR 激活剂;通过抑制自噬体和溶酶体之间的融合来抑制自噬过程,从而导致 LC3II 蛋白的积累和自噬体的增大。
-
产品描述MHY1485 is a mTOR activator; inhibits the autophagic process by inhibition of fusion between autophagosomes and lysosomes leading to the accumulation of LC3II protein and enlarged autophagosomes.(In Vitro):MHY1485 (10 μM; 4 hours) shows that GCDC-induced autophagic activity is inhibited by upregulating p-mTOR expression and downregulating LC3 and p62 expression in HCC cells.MHY1485 (5 μM; 6 hours) increases the LC3II/LC3I ratio in a dose and time-dependently manner due to presumably inhibited LC3II degradation in rat liver Ac2F cells.MHY1485 (0.5-2 μM; 6 hours) increases the phosphorylation of mTOR at ser2448 and upregulates the level of phosphorylation of 4E-BP1 in a dose-dependently manner in Ac2F cells.(In Vivo):MHY1485 (intraperitoneal injection; 10?mg/kg, 2 days) blocks the autophagy signaling induced by follicle-stimulating hormone (FSH). It increases p-mTOR and p-S6K1 expression levels, whereas LC3 expression shows no marked change compared to that in the control group.
-
体外实验MHY1485 (10 μM; 4 hours) shows that GCDC-induced autophagic activity is inhibited by upregulating p-mTOR expression and downregulating LC3 and p62 expression in HCC cells.MHY1485 (5 μM; 6 hours) increases the LC3II/LC3I ratio in a dose and time-dependently manner due to presumably inhibited LC3II degradation in rat liver Ac2F cells.MHY1485 (0.5-2 μM; 6 hours) increases the phosphorylation of mTOR at ser2448 and upregulates the level of phosphorylation of 4E-BP1 in a dose-dependently manner inAc2F cells. Western Blot Analysis Cell Line:HCC cells Concentration:10 μM Incubation Time:4 hours Result:Upregulated p-mTOR and downregulated LC3 and p62 expression.
-
体内实验MHY1485 (intraperitoneal injection; 10?mg/kg, 2 days) blocks the autophagy signaling induced by follicle-stimulating hormone (FSH).It increases p-mTOR and p-S6K1 expression levels,whereas LC3 expression shows no marked change compared to that in the control group. Animal Model:4-week-old female ICR mice Dosage:10?mg/kg, 2 days Administration:Intraperitoneal injection Result:Suppressed the autophagy level following FSH treatment.?
-
同义词MHY-1485 | MHY1485 | MHY 1485
-
通路PI3K/Akt/mTOR signaling
-
靶点mTOR
-
受体mTOR
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number326914-06-1
-
分子量387.39
-
分子式C17H21N7O4
-
纯度>98% (HPLC)
-
溶解度DMSO: 33 mg/mL (85.18 mM)
-
SMILESO=[N+](C1=CC=C(NC2=NC(N3CCOCC3)=NC(N4CCOCC4)=N2)C=C1)[O-]
-
化学全称4,6-dimorpholino-N-(4-nitrophenyl)-1,3,5-triazin-2-amine
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Choi YJ, et al. PLoS One. 2012, 7(8), e43418.
产品手册




关联产品
-
Zotarolimus
Zotarolimus (ABT-578, A 179578) 是雷帕霉素的半合成类似物,抑制 FKBP-12。
-
SPI--112Me
SPI--112Me 是 SPI-112 的前药,在无细胞试验中,它优先抑制 Shp2 的 PTPase 活性超过 Shp1 和 PTP1B 20 倍。
-
PQR-620
PQR-620 (PQR620) 是一种新型有效、选择性、脑渗透性 mTORC1/2 抑制剂。